Centre for Healthcare Science and Technology, Indian Institute of Engineering Science and Technology (IIEST), Shibpur, Howrah, West Bengal 711103, India.
Centre for Healthcare Science and Technology, Indian Institute of Engineering Science and Technology (IIEST), Shibpur, Howrah, West Bengal 711103, India.
Biophys Chem. 2021 Mar;270:106538. doi: 10.1016/j.bpc.2020.106538. Epub 2020 Dec 28.
The current global outbreak of COVID-19 due to SARS-CoV-2 is an unprecedented humanitarian crisis. Considering the gravity of its impact there is an immediate need to develop a detection technique that is sensitive, specific, fast, and affordable for the clinical diagnosis of the disease. Real time Polymerase Chain Reaction (RT-PCR)-based detection platforms are contemplated to be the gold standard to detect viral RNA. However, that may be susceptible to errors, and there is a risk of obtaining false results, which ultimately compromises the strategy of efficient disease management. Several modern techniques exhibiting assured results with enhanced sensitivity and specificity against the SARS-CoV-2 associated viral components or immune response against it have been developed and may be implemented. The review deals with the conventional RT-PCR detection techniques and compares them to other detection platforms viz., biosensor based detection of antigens, fluorescent or colorimetric detection systems including CRISPR-Cas 13 based SHERLOCK kit, CRISPR Cas-9 based FELUDA test kit, CRISPR DETECTR kit, Next Generation Sequencing or microarray-based kits. These modern techniques are great as a point of care detection methods but should be followed by RT PCR based detection for the confirmation of COVID-19 status.
当前由 SARS-CoV-2 引起的全球 COVID-19 爆发是一场前所未有的人道主义危机。考虑到其影响的严重性,立即需要开发一种灵敏、特异、快速且价格合理的检测技术,用于疾病的临床诊断。实时聚合酶链反应(RT-PCR)检测平台被认为是检测病毒 RNA 的金标准。然而,这可能容易出错,并且存在获得假结果的风险,这最终会影响到有效的疾病管理策略。已经开发出了几种现代技术,这些技术具有针对 SARS-CoV-2 相关病毒成分或针对其的免疫反应的增强的灵敏度和特异性,可确保获得可靠的结果,并可能得到实施。本文综述了传统的 RT-PCR 检测技术,并将其与其他检测平台(例如基于生物传感器的抗原检测、荧光或比色检测系统,包括基于 CRISPR-Cas13 的 SHERLOCK 试剂盒、基于 CRISPR Cas-9 的 FELUDA 检测试剂盒、CRISPR DETECTR 试剂盒、下一代测序或基于微阵列的试剂盒)进行了比较。这些现代技术非常适合作为即时检测方法,但应在 RT-PCR 检测后进行,以确认 COVID-19 的状态。